Market Place
Sourcing Support
Avion Pharma`s Dhivy® and advocateJoins Rock Steady Boxing Event
03 Oct 2024 //
PR NEWSWIRE
Amneal Launches CREXONT For Parkinson`s Disease Treatment
23 Sep 2024 //
BUSINESSWIRE
Amneal Receives FDA Approval For CREXONT To Treat Parkinson`s Disease
07 Aug 2024 //
BUSINESSWIRE
Amneal Clinches Approval For Extended-Release Parkinson`s Med
07 Aug 2024 //
FIERCE PHARMA
Merz wins $185m bid for bankrupt Acorda assets and increases US workforce by 50%
11 Jul 2024 //
PHARMACEUTICAL-TECHNOLOGY
Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics
10 Jul 2024 //
BUSINESSWIRE
US FDA rejects AbbVie`s Parkinson`s disease therapy for the second time
26 Jun 2024 //
FIERCE PHARMA
Rubicon`s Generic Carbidopa; Levodopa Receives Approval in US
04 Jun 2024 //
FDA
Mitsubishi Tanabe Pharma America Presents Positive Results from Pivotal Phase 3
29 Aug 2023 //
PR NEWSWIRE
JAMA Publishes Phase 3 Study Results Comparing IPX203 to Carbidopa/Levodopa
24 Aug 2023 //
BUSINESSWIRE
Vistagen Receives Notice of Allowance for AV-101 Canadian Patent
13 Jul 2023 //
BUSINESSWIRE
US FDA declines to approve AbbVie`s Parkinson`s disease therapy
23 Mar 2023 //
HEALTH ET
Enforcement Report - Week of March 8, 2023
08 Mar 2023 //
FDA
Acorda Announces Agreement with Catalent for Long-Term Global Supply of INBRIJA®
05 Jan 2023 //
BUSINESSWIRE
Aurobindo`s Generic Carbidopa, Levodopa Receives Approval in the U.S.
28 Nov 2022 //
FDA
Rubicon`s Generic Carbidopa, Levodopa Receives Approval in the U.S.
21 Sep 2022 //
FDA
Esteve Launches INBRIJA® in Germany
16 Jun 2022 //
BUSINESSWIRE
Cerevance outlines Phase II/III trial planned for Q1 2023
23 May 2022 //
CLINICALTRIALSARENA
BeyoND Phase 2b Data Indicates ND0612 Has Long-Term Safety Profile in PD
04 Apr 2022 //
PRNEWSWIRE
Acorda Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
09 Mar 2022 //
BUSINESSWIRE
Avion Pharma announces FDA approval and availability of DHIVY for Parkinson`s
14 Feb 2022 //
PRNEWSWIRE
Acorda Therapeutics Announces Agreement to Commercialize INBRIJA in Germany
09 Nov 2021 //
BIOSPACE
Acorda Reports Q3 2021 Financial Results, Additions to Leadership Team
09 Nov 2021 //
BUSINESSWIRE
AbbVie Eyes Potential Approval for Parkinson’s Treatment after +ve results
28 Oct 2021 //
BIOSPACE
ScieGen Pharma`s Generic Carbidopa;Levodopa Receives Approval in US
07 Oct 2021 //
FDA
Amneal’s IPX-203 shows promising results for motor fluctuations in PD
08 Sep 2021 //
PHARMAFILE
Amneal touts results of PIII Parkinson`s trial; NovaRock partners on cancer drug
26 Aug 2021 //
ENDPTS
Acorda Therapeutics Announces Repayment of Convertible Senior Notes
16 Jun 2021 //
BUSINESSWIRE
Bayer enters clinic with experimental cell, gene therapies for Parkinson`s
08 Jun 2021 //
BUSINESSWIRE
Sciegen Pharms Generic Carbidopa Levodopa Receives Approval In US
12 May 2021 //
FDA
Singapore Develops Single Daily Pill For Parkinson’s Disease
20 Sep 2020 //
BIOSPECTRUM ASIA
AbbVie to Present New Data of Parkinson`s Disease and Movement Disorders
11 Sep 2020 //
PRNNEWSWIRE
Levodopa may improve vision in patients with macular degeneration
10 Sep 2020 //
SCIENCE DAILY
Mylan Pharms`s Carbidopa;Entacapone;LevodopaTentative Approval in US
19 Aug 2020 //
FDA
Slow Inbrija launch forces Acorda to slash $800M sales hopes
14 Feb 2020 //
FIERCE PHARMA
Kyowa Kirin Announces Marketing Authorisation Application for Istradefylline
06 Jan 2020 //
PR NEWSWIRE
Lobsor Pharma receives Japanese patent for APD solution
31 Oct 2019 //
BIOSPECTRUMASIA
Kyowa Kirin Announces NOURIANZ™ (Istradefylline) Now Available in the U.S.
14 Oct 2019 //
BUSINESSWIRE
Mitsubishi Tanabe Announces Presentation of Patient-Reported Result ph 2 ND0612
23 Sep 2019 //
PR NEWSWIRE
Acorda Therapeutics Inbrija (levodopa) Receives Approval in Europe
19 Sep 2019 //
EMA
HiFiBiO`s Kite-backed C round; Kyowa Kirin`s Parkinson`s nod; Relief for Sun
30 Aug 2019 //
FIERCE PHARMA
FDA review finds no increased risk of prostate cancer Comtan, Stalevo
13 Aug 2019 //
FDA
Intec flunks phase 3 Parkinson`s test against Merck drug
23 Jul 2019 //
FIERCE BIOTECH
Modag raises series A round to test disease-modifying parkinsonian drug
27 Jun 2019 //
FIERCE BIOTECH
Intec Pharma Announces Results from Phase 2 Clinical Trial of Accordion Pill
25 Jun 2019 //
BIOSPACE
Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
21 Jun 2019 //
FIERCE PHARMA
Alembic Pharma gets USFDA nod for Parkinson`s disease treatment drugs
07 Jun 2019 //
ECONOMIC TIMES
Acorda Announces The Lancet Neurology Publication of Ph 3 Data for INBRIJA
18 Jan 2019 //
BUSINESSWIRE
Acorda Therapeutics Announces FDA Approves INBRIJA™ (levodopa inhalation powder)
28 Dec 2018 //
BUSINESSWIRE
Acorda pulls off delayed Parkinson’s approval for Inbrija
27 Dec 2018 //
FIERCE PHARMA
Acorda celebrates an FDA OK, so does that make them a takeover target?
22 Dec 2018 //
ENDPTS
Israel`s Intec Pharma eyes revenue from Parkinson`s drug in 2019
07 Nov 2018 //
REUTERS
Merck runs out of Parkinson’s disease drug Sinemet as manufacturing issues
04 Oct 2018 //
FIERCE PHARMA
FDA sets back review date of Acorda’s levodopa inhaler for Parkinson’s disease
14 Sep 2018 //
FIERCE BIOTECH
Acorda’s awful bad week gets worse as FDA hands execs another delay on Inbrija
13 Sep 2018 //
ENDPTS
U.S. appeals court invalidates Acorda patents on MS drug
11 Sep 2018 //
CNBC
Biohaven picks up AstraZeneca CNS drug, plans phase 3
07 Sep 2018 //
FIERCE BIOTECH
Acorda Therapeutics CTO Leaves To Helm Unnamed Biotech Company
14 Aug 2018 //
BIOSPACE
